Qiagen ( (QGEN) ) just unveiled an update.
QIAGEN N.V. has announced a release of voting rights as informed by the Netherlands Authority for the Financial Markets (AFM). The notification, involving a transaction dated April 7, 2025, highlights the involvement of Bank of America Corporation and its affiliates in holding shares and voting rights in QIAGEN. This disclosure underscores the significant shareholding and potential influence of Bank of America and its subsidiaries on QIAGEN, reflecting on the company’s governance and shareholder structure.
More about Qiagen
QIAGEN N.V. operates in the biotechnology industry, specializing in providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is known for its products that enable the isolation and processing of DNA, RNA, and proteins, serving a global market with a focus on enhancing the capabilities of laboratories and research institutions.
YTD Price Performance: -10.04%
Average Trading Volume: 1,348,249
Technical Sentiment Signal: Strong Buy
Current Market Cap: $8.95B
Learn more about QGEN stock on TipRanks’ Stock Analysis page.